부산대학교 도서관

Pascual, J; Attard, G; Bidard, F-C; Curigliano, G; De, Mattos-Arruda L; Diehn, M; Italiano, A; Lindberg, J; Merker, JD; Montagut, C

ANNALS OF ONCOLOGY. 33(8):750-768

Mayer EL; Dana-Farber Cancer Institute, Boston, USA. Electronic address: erica_mayer@dfci.harvard.edu.; Bidard FC; Institut Curie, Paris, France.; Park YH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Janni W; Universitätsklinikum Ulm, Ulm, Germany.; Ma C; Washington University School of Medicine, Saint Louis, USA.; Cristofanilli M; Weill-Cornell Medicine/New York-Presbyterian Hospital, New York, USA.; Iwata H; Nagoya City University, Nagoya, Japan.; Bianchini G; IRCCS Ospedale San Raffaele, Milan, Italy.; Kalinsky K; Winship Cancer Institute, Atlanta, Canada.; Chia S; BC Cancer Agency, Vancouver, Canada.; Brufsky A; UMPC Magee-Womens Hospital, Pittsburgh, USA.; Fasching PA; University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.; Nowecki Z; Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie, Warsaw, Poland.; Chen SC; Chang Gung Medical Foundation Linkou Branch, Taoyuan City, Taiwan.; Pascual J; Medical Oncology Department, Hospital Universitario Virgen de la Victoria, IBIMA, Málaga, Spain.; Moreau L; Pôle Santé République, Clermont-Ferrand, France.; Ruiz-Borrego M; Hospital Universitario Virgen del Rocio, Seville, Spain.; Shai A; Oncology Wing, RAMBAM Health Care Campus, Haifa, Israel.; Karadurmus N; Gülhane Training and Research Hospital, University of Health Sciences, Ankara, Turkey.; Sohn JH; Yonsei University, Seoul, Republic of Korea.; Zhu Y; Evinova, Oncology R&D, AstraZeneca, Waltham, USA.; Leddin I; Late Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Miralles MS; Late Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Bartlett CH; Late Development, Oncology R&D, AstraZeneca, Gaithersburg, USA.; Turner N; Royal Marsden Hospital, London, UK.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Dathathri E; Department of Medical Cell Biophysics, TechMed Center, Faculty of Science and Technology, University of Twente, Enschede, The Netherlands.; Nanou A; Department of Medical Cell Biophysics, TechMed Center, Faculty of Science and Technology, University of Twente, Enschede, The Netherlands.; Bidard FC; Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France; Circulating Tumor Biomarkers Laboratory, Siric, Institut Curie, PSL Research University, Paris, France; UVSQ, Paris-Saclay University, Paris, France.; Renault S; Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France; Circulating Tumor Biomarkers Laboratory, Siric, Institut Curie, PSL Research University, Paris, France; UVSQ, Paris-Saclay University, Paris, France.; Pierga JY; Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France; Circulating Tumor Biomarkers Laboratory, Siric, Institut Curie, PSL Research University, Paris, France; Université Paris Descartes, Paris, France.; de Bono J; The Institute of Cancer Research and Royal Marsden Hospital, London, UK.; Terstappen L; Department of Medical Cell Biophysics, TechMed Center, Faculty of Science and Technology, University of Twente, Enschede, The Netherlands; Department of General, Visceral and Pediatric Surgery, Heinrich-Heine University, University Hospital Düsseldorf, Düsseldorf, Germany; Decisive Science, Amsterdam, The Netherlands.; Coumans FAW; Decisive Science, Amsterdam, The Netherlands. Electronic address: frank@decisivescience.com.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Poumeaud F; Department of Medical Oncology, Oncopole Claudius Regaud, IUCT-O, Toulouse, France. poumeaud.francois@iuct-oncopole.fr.; Morisseau M; Biostatistics & Health Data Science Unit, Oncopole Claudius Regaud IUCT-O, Toulouse, France.; Cabel L; Department of Medical Oncology, Institut Curie, Paris, France.; Gonçalves A; Aix-Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, Department of Medical Oncology, CRCM, Marseille, France.; Rivier C; Department of Medical Oncology, Centre Léon Bérard, Cancer Research Center of Lyon (UMR Inserm 1052 - CNRS 5286), Lyon, France.; Trédan O; Department of Medical Oncology, Centre Léon Bérard, Cancer Research Center of Lyon (UMR Inserm 1052 - CNRS 5286), Lyon, France.; Volant E; Department of Medical Oncology, Institut de cancérologie de l'Ouest, Saint-Herblain, France.; Frenel JS; Department of Medical Oncology, Institut de cancérologie de l'Ouest, Saint-Herblain, France.; Ladoire S; Department of Medical Oncology, Centre Georges-François Leclerc, INSERM U1231, Dijon, France.; Jacot W; Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier University, INSERM U1194, Montpellier, France.; Jamelot M; Department of Medical Oncology and Cellular Therapy, Faculté de médecine Sorbonne Université, Hôpital Tenon, Paris, France.; Foka Tichoue H; Department of Medical Oncology, Hôpital de la Pitié-Salpêtrière, Institut Universitaire de Cancérologie AP-HP, Sorbonne Université, Paris, France.; Patsouris A; Department of Medical Oncology, Institut de Cancérologie de l'Ouest Pays de la Loire, Angers, France.; Teixeira L; Department of Medical Oncology, INSERM U976, Université de Paris Cité, Hopital Saint Louis, Paris, France.; Bidard FC; Department of Medical Oncology, Institut Curie, Saint-Cloud, France.; Versailles Saint-Quentin University, Paris Saclay, Saint-Cloud, France.; Loirat D; Department of Medical Oncology, Institut Curie, Paris, France.; Brunet M; Clinical Trials Department - Breast Cancers, Institut Bergonié, Bordeaux, France.; Levy C; Department of Medical Oncology, Centre François Baclesse, Caen, France.; Bailleux C; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France.; Cabarrou B; Biostatistics & Health Data Science Unit, Oncopole Claudius Regaud IUCT-O, Toulouse, France.; Deleuze A; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France.; Uwer L; Department of Medical Oncology, Institut de Cancérologie de Lorraine, Nancy, France.; Deluche E; Department of Medical Oncology, Centre Hospitalier Universitaire de Limoges, Limoges, France.; Grellety T; Department of Medical Oncology, Centre Hospitalier de la côte basque, Bayonne, France.; Franchet C; Department of Pathology, Oncopole Claudius Regaud, IUCT-O, Toulouse, France.; Fiteni F; Department of Medical Oncology, University Hospital, Nimes, France.; UMR INSERM IDESP-Desbrest Institute of Epidemiology and Public Health, University of Montpellier, Montpellier, France.; Bischoff H; Department of Medical Oncology, Institut de Cancérologie de Strasbourg Europe, Strasbourg, France.; Vion R; Department of Medical Oncology, Centre Henri Becquerel, Rouen, France.; Pagliuca M; University Paris-Saclay, Gustave Roussy, INSERM U981, Molecular Predictors and New Targets in Oncology, Villejuif, France.; Division of Breast Medical Oncology, Instituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italia.; Verret B; Departmentof Medical Oncology, Institut Gustave Roussy, Paris, France.; Bécourt S; Department of Medical Oncology, Centre Oscar Lambret, Lille, France.; Reverdy T; Department of Medical Oncology, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), Université Lyon 1, Lyon, France.; de Nonneville A; Aix-Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, Department of Medical Oncology, CRCM, Marseille, France.; Dalenc F; Department of Medical Oncology, Oncopole Claudius Regaud, IUCT-O, Toulouse, France.

Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

Valenza C; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Trapani D; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Bidard FC; Department of Medical Oncology, Institut Curie, Paris and Saint-Cloud, France; Department of Medical Oncology, Université de Versailles Saint-Quentin, Université Paris-Saclay, Saint-Cloud, France.; Gligorov J; Department of Medical Oncology, Institut Universitaire de Cancérologie, Sorbonne University, AP-HP, Tenon Hospital, Paris, France.; Cortés J; International Breast Cancer Center (IBCC), Pangaea Oncology, Quironsalud Group, Barcelona; IOB Madrid, Hospital Beata Maria Ana, Madrid; Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain; Oncoclínicas&Co, Jersey City, USA, Sao Paulo, Brazil.; Turner N; Breast Cancer Now Research Centre, Institute of Cancer Research, London; Ralph Lauren Centre for Breast Cancer Research and Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK.; Dalenc F; Department of Medical Oncology, Oncopole Claudius Regaud-IUCT, Inserm, Toulouse.; Penault-Llorca F; Department of Pathology and Biopathology, Centre de Lutte Contre le Cancer Jean Perrin, Imagerie Moléculaire et Stratégies Théranostiques, Université Clermont Auvergne, UMR 1240 INSERM-UCA, Clermont-Ferrand.; Freyer G; Department of Medical Oncology, HCL Cancer Institute, Lyon; Department of Medical Oncology, Lyon 1 University, Lyon.; Arnedos M; Department of Medical Oncology Bordeaux, Institut Bergonié, Bordeaux.; Villanueva C; Clinique Clémentville, Montpellier, France.; Loibl S; Center for Hematology and Oncology Bethanien, Frankfurt, Germany.; Pistilli B; Department of Medical Oncology, Gustave Roussy Cancer Center, Villejuif, France.; Curigliano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Electronic address: giuseppe.curigliano@ieo.it.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Van Baelen, K.; Geukens, T.; Maetens, M.; Tjan-Heijnen, V; Lord, C. J.; Linn, S.; Bidard, F-C; Richard, F.; Yang, W. W.; Steele, R. E.; Pettitt, S. J.; Van Ongeval, C.; De Schepper, M.; Isnaldi, E.; Nevelsteen, I; Smeets, A.; Punie, K.; Voorwerk, L.; Wildiers, H.; Floris, G.; Vincent-Salomon, A.; Derksen, P. W. B.; Neven, P.; Senkus, E.; Sawyer, E.; Kok, M.; Desmedt, C.

ANNALS OF ONCOLOGY; AUG 2022, 33 8, p769-p785, 17p.

Cabel, L.; Bonneau, C.; Bernard-Tessier, A.; Hequet, D.; Tran-Perennou, C.; Bataillon, G.; Rouzier, R.; Feron, J-G; Fourchotte, V; Le Brun, J-F; Benoit, C.; Rodrigues, M.; Scher, N.; Minsat, M.; Legrier, M-E; Bieche, I; Proudhon, C.; Sastre-Garau, X.; Bidard, F-C; Jeannot, E.

ESMO OPEN; JUN 2021, 6 3, p100154 8p.

Jhaveri K; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York; Weill Cornell Medical College, New York. Electronic address: jhaverik@mskcc.org.; Eli LD; Clinical Development, Puma Biotechnology, Los Angeles, USA.; Wildiers H; University Hospitals Leuven, Leuven, Belgium.; Hurvitz SA; David Geffen School of Medicine, UCLA, Los Angeles, Santa Monica, USA.; Guerrero-Zotano A; Medical Oncology Department, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Unni N; UT Southwestern Medical Center, Dallas.; Brufsky A; Magee-Womens Hospital of UPMC, Pittsburgh.; Park H; Washington University School of Medicine, St. Louis.; Waisman J; City of Hope Comprehensive Cancer Center, Duarte.; Yang ES; University of Alabama at Birmingham, Birmingham, USA.; Spanggaard I; Department of Oncology, Rigshospitalet - Copenhagen University Hospital, Copenhagen, Denmark.; Reid S; Division of Hematology/Oncology (Breast Oncology), The Vanderbilt-Ingram Cancer Center, Nashville.; Burkard ME; Division of Hematology/Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison.; Vinayak S; Seattle Cancer Care Alliance, Seattle, USA.; Prat A; Hospital Clínic de Barcelona, Barcelona, Spain.; Arnedos M; Department of Medical Oncology, Gustave Roussy, Villejuif.; Bidard FC; Department of Medical Oncology, UVSQ/Paris-Saclay University, Institut Curie, Saint Cloud, France.; Loi S; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Australia.; Crown J; St. Vincent's University Hospital, Dublin, Ireland.; Bhave M; Department of Hematology/Oncology, Emory University, Winship Cancer Institute, Atlanta.; Piha-Paul SA; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston.; Suga JM; Kaiser Permanente, Department of Medical Oncology, Vallejo, USA.; Chia S; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada.; Saura C; Medical Oncology Service, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona.; Garcia-Saenz JÁ; Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), CIBERONC, Madrid.; Gambardella V; Hospital Clínico de Valencia, Instituto de Investigación Sanitaria INCLIVA, Valencia.; de Miguel MJ; START Madrid - Hospital Universitario Madrid Sanchinarro, Madrid, Spain.; Gal-Yam EN; Institute of Breast Oncology, Sheba Medical Center, Ramat Gan.; Rapael A; Sourasky Medical Center, Tel Aviv.; Stemmer SM; Davidoff Cancer Center, Rabin Medical Center, Petah Tikva; Tel Aviv University, Tel Aviv, Israel.; Ma C; Division of Medical Oncology, Department of Medicine and Siteman Cancer Center, Washington University, St. Louis.; Hanker AB; UT Southwestern Simmons Comprehensive Cancer Center, Dallas.; Ye D; UT Southwestern Simmons Comprehensive Cancer Center, Dallas.; Goldman JW; UCLA Hematology & Oncology, Santa Monica.; Bose R; Division of Medical Oncology, Department of Medicine and Siteman Cancer Center, Washington University, St. Louis.; Peterson L; Division of Medical Oncology, Department of Medicine and Siteman Cancer Center, Washington University, St. Louis.; Bell JSK; Tempus Labs, Chicago, USA.; Frazier A; Clinical Development, Puma Biotechnology, Los Angeles, USA.; DiPrimeo D; Clinical Development, Puma Biotechnology, Los Angeles, USA.; Wong A; Clinical Development, Puma Biotechnology, Los Angeles, USA.; Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas.; Solit DB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Bidard, F-C; Tournigand, C; André, T; Mabro, M; Figer, A; Cervantes, A; Lledo, G; Bengrine-Lefevre, L; Maindrault-Goebel, F; Louvet, C; de Gramont, A

Annals of Oncology. Jun 01, 2009 20(6):1042-1047

Van Baelen, K; Geukens, T; Maetens, M; Tjan-Heijnen, V; Lord, C J; Linn, S; Bidard, F-C; Richard, F; Yang, W W; Steele, R E; Pettitt, S J; Van Ongeval, C; De Schepper, M; Isnaldi, E; Nevelsteen, I; Smeets, A; Punie, K; Voorwerk, L; Wildiers, H; Floris, G; Vincent Salomon, A; Derksen, P W B; Neven, P; Senkus, E; Sawyer, E; Kok, M; Desmedt, C

Annals of Oncology. 34(3):326-326

Hartkopf, AD; Brucker, SY; Taran, F-A; Harbeck, N; von Au, A; Naume, B; Pierga, J-Y; Hoffmann, O; Beckmann, MW; Rydén, L; Fehm, T; Aft, R; Montserrat, S; Walter, V; Rack, B; Schuetz, F; Borgen, E; Ta, M-H; Bittner, A-K; Fasching, P; Fernö, M; Krawczyk, N; Weilbaecher, K; Margelí, M; Hahn, M; Jueckstock, J; Domschke, C; Bidard, F-C; Kasimir-Bauer, Sabine; Schoenfisch, B; Kurt, AG; Wallwiener, M; Gebauer, G; Wallwiener, D; Janni, W; Pantel, K

Pierga, J-Y; Bidard, F-C; Autret, A.; Petit, T.; Andre, F.; Dalenc, F.; Levy, C.; Ferrero, J-M; Romieu, G.; Bonneterre, J.; Lerebours, F.; Bachelot, T.; Kerbrat, P.; Campone, M.; Eymard, J-C; Mouret-Reynier, M-A; Gligorov, J.; Hardy-Bessard, A-C; Lortholary, A.; Soulie, P.; Boher, J-M; Proudhon, C.; Charafe-Jaufret, E.; Lemonnier, J.; Bertucci, F.; Viens, P.

ANNALS OF ONCOLOGY; JAN 2017, 28 1, p103-p109, 7p.

Pierga, J-Y; Silveira, A.; Lorgis, V.; Tanguy, M-L; Tredan, O.; Dubot, C.; Jacot, W.; Goncalves, A.; Debled, M.; Levy, C.; Ferrero, J-M; Jouannaud, C.; Luporsi, E.; Mouret-Reynier, M-A; Dalenc, F.; Lemonnier, J.; Berger, F.; Proudon, C.; Bidard, F-C

CANCER RESEARCH; FEB 2019, 79 4, 3p. Supplement: S

Bidard, F-C; Pistilli, B.; Dalenc, F.; Rouge, T. De la Motte; Sabatier, R.; Frenel, J-S; Ladoire, S.; Dubot, C.; Ferrero, J-M; Levy, C.; Lortholary, A.; Stefani, L.; Mouret-Reynier, M-A; Hardy, A-C; Jacquin, J-P; Grenier, J.; Chakiba, C.; Teixeira, L.; Soulie, P.; Everhard, S.; Lemonnier, J.; Jeannot, E.; Bieche, I.; Berger, F.; Pierga, J-Y; Bachelot, T.; Delaloge, S.

CANCER RESEARCH; FEB 2019, 79 4, 3p. Supplement: S

Bidard, F-C; Jacot, W.; Dureau, S.; Brain, E.; Bachelot, T.; Bourgeois, H.; Goncalves, A.; Ladoire, S.; Naman, H.; Dalenc, F.; Gligorov, J.; Espie, M.; Levy, C.; Ferrero, J-M; Loirat, D.; Cottu, P.; Dieras, V.; Simondi, C.; Berger, F.; Alix-Panabieres, C.; Pierga, J-Y

CANCER RESEARCH; FEB 2019, 79 4, 3p. Supplement: S

Ignatiadis, M; Riethdorf, S; Bidard, F-C; Vaucher, I; Khazour, M; Roth, F; Metallo, J; Rouas, G; Payne, RE; Coombes, RC; Teufel, I; Andergassen, U; Apostolaki, S; Politaki, E; Mavroudis, D; Bessi, S; Pestrin, M; Di Leo, A; Campion, M; Reinholz, M; Perez, E; Piccart, M; Borgen, E; Naume, B; Jimenez, J; Aura, CM; Zorzino, L; Cassatella, MC; Sandri, MT; Mostert, B; Sleijfer, S; Kraan, J; Janni, W; Fehm, T; Rack, B; Terstappen, L; Repollet, M; Pierga, J-Y; Miller, C; Sotiriou, C; Michiels, S; Pantel, K

Breast Cancer Res
Breast cancer research, 16 (2

Pierga, J-Y; Tredant, O.; Chevrier, M.; Dubot, C.; Lorgis, V.; Romieu, G.; Goncalves, A.; Debled, M.; Levy, C.; Ferrero, J-M; Jouannaud, C.; Luporsi, E.; Mouret-Reynier, M-A; Dalenc, F.; Berger, F.; Lemonnier, J.; Proudhon, C.; Bidard, F-C

CANCER RESEARCH; FEB 2017, 77 3p. Supplement: 4

Bidard, F-C; Michiels, S.; Mueller, V.; Riethdorf, S.; Esserman, L. J.; Lucci, A.; Naume, B.; Horiguchi, J.; Gisbert-Criado, R.; Sleijfer, S.; Toi, M.; Garcia-Saenz, Ja; Hartkopf, A.; Generali, D.; Rothe, F.; Smerage, J.; Muinelo, L.; Stebbing, J.; Viens, P.; Magbanua, M.; Hall, C. S.; Engebratenm, O.; Takata, D.; Vidal-Martinez, J.; Onstenk, W.; Fujisawa, N.; Diaz-Rubio, E.; Taran, F-A; Cappelletti, M. R.; Ignatiadis, M.; Name, N.; Proudhon, C.; Wolf, D.; Bauldry, J. Bowman; Borgen, E.; Nagaoka, R.; Caranana, V.; Kraan, J.; Maestro, M.; Brucker, S. Y.; Weber, K.; Reyal, F.; Amara, D.; Karhade, M. Gopalkrishna; Mathiesen, R. Ruud; Tokiniwa, H.; Llombart-Cussac, A.; D'Hollander, K.; Cottu, P.; Park, J. W.; Loibl, S.; Pierga, J-Y; Pantel, K.

CANCER RESEARCH; FEB 2017, 77 3p. Supplement: 4

Pierga JY; Bidard FC; Denis MG; de Cremoux P

Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

De Mattos-Arruda L; Weigelt B; Cortes J; Won HH; Ng CKY; Nuciforo P; Bidard FC; Aura C; Saura C; Peg V; Piscuoglio S; Oliveira M; Smolders Y; Patel P; Norton L; Tabernero J; Berger MF; Seoane J; Reis-Filho JS

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: PubMed not MEDLINE